MassDevice

Abbott: Study shows neuromod systems greatly reduce pain-related healthcare visits

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Pharmabiz

Five-year data shows Abbott neuromodulation systems reduce healthcare visits related to pain and deliver sustained relief

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...

Abbott Laboratories (NYSE:ABT) Q4 2025 earnings call transcript

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
Scientific American

U.S. Approves First Device to Treat Depression with Brain Stimulation at Home

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...